Overview

• Blume Ventures led the Series A, with new backers Schema Ventures and Vicus Ventures joining and prior investors Together Fund, DeVC and Medmountain Ventures participating, alongside strategic investors Innovaccer and Memora Health as reported.
• Confido reports a roughly 10x surge in revenue and says its platform now serves more than 1 million patients, up from about 150,000 in December 2024.
• The company’s agents answer on the first ring, authenticate callers, handle scheduling, refills, payments and other workflows, write interactions back to EHRs, and warm‑transfer complex cases to staff.
• Customer Dallas Renal Group reports inbound wait times fell from minutes to about 15 seconds and more than two‑thirds of patients confirm appointments on outbound calls, with automation rates reported above 80% and a 95% call‑handling claim by the CEO.
• Confido plans to expand into patient recalls and care coordination as rivals raise sizable rounds, and Nova Advisor estimates the AI voice‑agent market could grow from $468 million to nearly $11.6 billion by 2034.